Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Athira Pharma
4000 Mason Rd, Suite 300
Seattle, WA 98195
Phone: 206-221-8112
https://athira.com/

Athira is a clinical stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is currently advancing its lead therapeutic candidate, NDX-1017, a novel small molecule, in later-stage clinical trials for Alzheimer's. For more information, visit www.athira.com. You can also follow Athira on Facebook, LinkedIn and @athirapharma on Twitter and Instagram.Athira, headquartered in Seattle, is a clinical stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is currently advancing its lead therapeutic candidate, NDX-1017, a novel small molecule, in later-stage clinical trials for Alzheimer's.

Key Contact
Name
Leen Kawas
Title
President & CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
06/04/20 $85,000,000 Series B Franklin Templeton
Highside Capital Management
Janus Henderson Investors
LifeSci Venture Partners
Logos Capital
Perceptive Advisors
Rock Springs Capital
RTW Investments
Sofinnova Ventures
Surveyor Capital
Venrock Healthcare Partners
Viking Global Investors
undisclosed